Trial Outcomes & Findings for Lateral Versus Anterior Spanning External Fixator for Tibial Plateau Fractures (NCT NCT00610701)

NCT ID: NCT00610701

Last Updated: 2017-07-24

Results Overview

measurement of quadriceps muscle strength at final followup = 1 year data at interim time points recorded, but only final reported for this purpose

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

35 participants

Primary outcome timeframe

(admission, 6 weeks, 3 months, 6 months) 1 year

Results posted on

2017-07-24

Participant Flow

Participant milestones

Participant milestones
Measure
1 Anterior
Anterior Anterior pin placement: Anteriorly-placed (front of the leg) femoral external fixator pins
2 Lateral
Lateral Lateral pin placement: Laterally-placed (side of the leg) femoral external fixator pind
Overall Study
STARTED
15
20
Overall Study
COMPLETED
5
9
Overall Study
NOT COMPLETED
10
11

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Lateral Versus Anterior Spanning External Fixator for Tibial Plateau Fractures

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
1-anterior Pin Placement
n=5 Participants
Anterior Anterior pin placement: Anteriorly-placed (front of the leg) femoral external fixator pins
2-lateral Pin Placement
n=9 Participants
Lateral Lateral pin placement: Laterally-placed (side of the leg) femoral external fixator pind
Total
n=14 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
5 Participants
n=5 Participants
9 Participants
n=7 Participants
14 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Sex: Female, Male
Female
2 Participants
n=5 Participants
5 Participants
n=7 Participants
7 Participants
n=5 Participants
Sex: Female, Male
Male
3 Participants
n=5 Participants
4 Participants
n=7 Participants
7 Participants
n=5 Participants
Region of Enrollment
United States
5 participants
n=5 Participants
9 participants
n=7 Participants
14 participants
n=5 Participants

PRIMARY outcome

Timeframe: (admission, 6 weeks, 3 months, 6 months) 1 year

measurement of quadriceps muscle strength at final followup = 1 year data at interim time points recorded, but only final reported for this purpose

Outcome measures

Outcome measures
Measure
1-anterior Pin Placement
n=5 Participants
Anterior Anterior pin placement: Anteriorly-placed (front of the leg) femoral external fixator pins
2-lateral Pin Placement
n=9 Participants
Lateral Lateral pin placement: Laterally-placed (side of the leg) femoral external fixator pind
Quadriceps Strength
35.9 Nm
Standard Deviation 10.7
39.6 Nm
Standard Deviation 17.7

Adverse Events

1 Anterior

Serious events: 2 serious events
Other events: 0 other events
Deaths: 0 deaths

2 Lateral

Serious events: 3 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
1 Anterior
n=5 participants at risk
Anterior Anterior pin placement: Anteriorly-placed (front of the leg) femoral external fixator pins
2 Lateral
n=9 participants at risk
Lateral Lateral pin placement: Laterally-placed (side of the leg) femoral external fixator pind
Injury, poisoning and procedural complications
death
20.0%
1/5 • Number of events 1 • 1 year
14 patients completed the study
22.2%
2/9 • Number of events 2 • 1 year
14 patients completed the study
Infections and infestations
infection
0.00%
0/5 • 1 year
14 patients completed the study
11.1%
1/9 • Number of events 1 • 1 year
14 patients completed the study
Musculoskeletal and connective tissue disorders
arthrofibrosis
20.0%
1/5 • Number of events 1 • 1 year
14 patients completed the study
0.00%
0/9 • 1 year
14 patients completed the study

Other adverse events

Adverse event data not reported

Additional Information

Brett D. Crist, MD

University of Missouri

Phone: 5738826562

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place